|
|
Venetoclax-Targeted Therapy in t(11;14) AL Amyloidosis Patients after Frontline Daratumumab and Cybord: A Retrospective Analysis from the French Amyloidosis Network
Murielle Roussel
,
Michelle Pirotte
,
Ornella Rizzo
,
Kentin Queru
,
Thomas Chalopin
et al.
Conference papers
hal-04071489v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study
Karim Labreche
,
Mailys Daniau
,
Amit Sud
,
Philip J Law
,
Louis Royer-Perron
et al.
Journal articles
hal-02328989v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
Arthur Bobin
,
Maéva Kyheng
,
Stephanie Guidez
,
Cecile Gruchet-Merouze
,
Valentine Richez
et al.
Journal articles
hal-03476700v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III).
Arnaud Jaccard
,
Raymond L. Comenzo
,
Parameswaran Hari
,
Philip N. Hawkins
,
Murielle Roussel
et al.
Journal articles
hal-01064573v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03) / 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL
Xavier Leleu
,
Lionel Karlin
,
Brigitte Kolb
,
Mourad Tiab
,
Carla Araujo
et al.
Blood, 2015, 126 (23), pp.3028
Journal articles
hal-01290431v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier
,
Caroline Houillier
,
Carole Soussain
,
Hervé Ghesquières
,
Olivier Chinot
et al.
Journal articles
hal-01290413v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency
Hélène Coignard-Biehler
,
Nizar Mahlaoui
,
Benoît Pilmis
,
Vincent Barlogis
,
Pauline Brosselin
et al.
Journal articles
hal-02377907v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Prospective Phase II Trial of Lenalidomide and Dexamethasone (Len-Dex) in POEMS Syndrome
Arnaud Jaccard
,
A. Danielou-Lazareth
,
L. Karlin
,
S. Choquet
,
L. Frenzel
et al.
Conference papers
hal-01228183v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry
Nizar Mahlaoui
,
Capucine Picard
,
Perrine Bach
,
Laurence Costes
,
Virginie Courteille
et al.
Journal articles
hal-02015219v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill
,
Asma Beldi-Ferchiou
,
Marion Alcantara
,
Victoria Cacheux
,
Violaine Safar
et al.
Journal articles
hal-03012903v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|